POINT Biopharma Global Inc.
Overview
POINT Biopharma Global Inc. is a clinical-stage pharmaceutical company focused on developing radioligand therapies for the treatment of cancer. The company's innovative approach aims to improve patient outcomes through targeted and precise radiotherapy solutions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to POINT Biopharma Global Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this POINT Biopharma Global Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.